Treatment of allergy with thymopentin
AssigneeOrtho Pharmaceutical Corporation
InventorGideon Goldstein
Life of this patent
Estimating the term…
Abstract
A method for treating allergy by administration of the peptide thymopentin.
Claims10
A method of palliating, in a human, the sneezing, runny nose, red eyes, itchy eyes or cough symptoms of type I hypersensitivity to environmental antigens resulting from the action of mediators released when IgE antibodies react with said antigens comprising administering to said human an effective symptom palliating amount of thymopentin or a pharmaceutically-acceptable salt thereof.
A method of palliating the symptoms of allergic rhinitis in a human having said symptoms which comprises administering to said human by intravenous injection an effective allergy palliating amount of thymopentin or a pharmaceutically-acceptable salt thereof.
A method for palliating the symptoms of allergic rhinitis in a human having said symptoms which comprises administering to said human by subcutaneous injection an effective allergy palliating amount of thymopentin or a pharmaceutically-acceptable salt thereof.
Dependencies are inferred from the claim text.